[The Clinical Significance of ARHGAP10 Alterations in Acute Myeloid Leukemia].

Authors

Ting-Ting DU, Zi-Jun Xu, Xiang-Mei Wen, Wei Zhao, Su-Wan Liu, Jun Qian, Jiang Lin

Published in

Zhongguo shi yan xue ye xue za zhi. Volume 34. Issue 3. Pages 621-628.

Abstract

To investigate the expression and methylation alterations of ARHGAP10 in AML and to further explore its clinical significance.
ARHGAP10 expression was measured by RT-qPCR in 18 controls and 68 AML patients. ARHGAP10 methylation was assessed using targeted sulfite sequencing in 25 controls and 102 AML patients. The clinical significance of ARHGAP10 expression and methylation changes in AML was further analyzed.
Analysis of publicly available datasets identified increased expression of ARHGAP10 in AML patients, which was further validated in our hospital cohort. Among the FAB subtypes, ARHGAP10 expression was significantly higher in the M2 and M5 subgroups compared to the control group. ROC curve analysis indicated that ARHGAP10 expression could be a potential diagnostic biomarker for AML. Kaplan-Meier analysis showed that high ARHGAP10expression and ARHGAP10 hypomethylation were associated with shorter overall survival. Furthermore, ARHGAP10 hypomethylation was observed in AML patients, and further analysis revealed a negative correlation between ARHGAP10 methylation level and expression level.
ARHGAP10 exhibits high expression and hypomethylation changes in AML, and these alterations may serve as potential indicators of poor prognosis in AML patients.

PMID:
42544646
Bibliographic data and abstract were imported from PubMed on 03 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.